Recent Finacing
Recent Raise
ApcinteX is a Cambridge University spin‑out developing therapeutics for haemophilia that reduce activity of a natural anticoagulant pathway to restore clotting across haemophilia types, including inhibitor patients.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors